Overview of Immunotherapy in Alzheimer’s Disease (AD) and Mechanisms of IVIG Neuroprotection in Preclinical Models of AD

Documenti analoghi

• Intravenous Immunoglobulin (IVIG) treatment exerts antioxidant and neuropreservatory effects in preclinical models of Alzheimer’s disease
  di: Counts, Scott, et al.
  Pubblicazione: (2014)
• Disease progression modelling from preclinical Alzheimer’s disease (AD) to AD dementia
  di: Cho, Soo Hyun, et al.
  Pubblicazione: (2021)
• Neuroprotective Role for Galanin in Alzheimer’s Disease
  di: Counts, Scott E., et al.
  Pubblicazione: (2010)
• Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models
  di: Webster, Scott J., et al.
  Pubblicazione: (2014)
• Galanin in Alzheimer’s disease: Neuroinhibitory or neuroprotective?
  di: Counts, S. E., et al.
  Pubblicazione: (2008)